Trials / Completed
CompletedNCT01057628
A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients
Phase III Study of ASP1941 -A Phase III, Randomized, Double-Blind, Placebo-controlled, Monotherapy Study to Assess the Efficacy, Safety, and Tolerability of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is to compare the efficacy and safety of ASP1941 with placebo in Japanese patients with type 2 diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ipragliflozin | oral |
| DRUG | placebo | oral |
Timeline
- Start date
- 2010-01-13
- Primary completion
- 2010-11-06
- Completion
- 2010-11-06
- First posted
- 2010-01-27
- Last updated
- 2025-05-30
Locations
5 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01057628. Inclusion in this directory is not an endorsement.